Westchester Capital Management (New York)’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,194,267
Closed -$12.4M 357
2023
Q2
$12.4M Buy
1,194,267
+227,332
+24% +$2.34M 0.39% 52
2023
Q1
$9.88M Buy
966,935
+170,779
+21% +$1.73M 0.3% 98
2022
Q4
$7.98M Buy
796,156
+140,000
+21% +$1.39M 0.22% 108
2022
Q3
$6.41M Buy
656,156
+7,500
+1% +$73K 0.18% 92
2022
Q2
$6.3M Hold
648,656
0.18% 88
2022
Q1
$6.28M Buy
648,656
+17,207
+3% +$166K 0.17% 91
2021
Q4
$6.16M Buy
+631,449
New +$6.13M 0.18% 74

Westchester Capital Management (New York)'s AFTR Position: Q3 2023 in Review

Westchester Capital Management (New York) sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 1,194,267 shares — an estimated $12.4M sold.

Westchester Capital Management (New York) first reported a position in AFTR in Q4 2021 and held it in 7 quarters. The position peaked at $12.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

  • Westchester Capital Management (New York) reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 1,194,267 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $12.4M.
  • Westchester Capital Management (New York) first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 7 quarters.
  • Westchester Capital Management (New York)'s AfterNext HealthTech Acquisition Corp position peaked at $12.4M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2023, filed 8 Nov 2023.